Clinical implications of new mechanistic insights into atopic dermatitis

Current Opinion in Pediatrics

Volumn 28, Issue 4, 2016, Pages 456-462

  Leung, Donald Y M ^a,b  

^a DEPARTMENT OF MEDICINE   (United States)

^b GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

atopic dermatitis; eczema; immune response; skin barrier; staphylococcus

Indexed keywords

CALCINEURIN INHIBITOR; CORTICOSTEROID; EMOLLIENT AGENT; IMMUNOSUPPRESSIVE AGENT; MELATONIN; ALLERGEN; SKIN CREAM;

ATOPIC DERMATITIS; FOOD ALLERGY; HUMAN; MICROBIOME; NONHUMAN; PHOTOTHERAPY; PRIORITY JOURNAL; REVIEW; SKIN INFECTION; SYSTEMIC DISEASE; ENVIRONMENTAL EXPOSURE; EVIDENCE BASED MEDICINE; GENOTYPE ENVIRONMENT INTERACTION; IMMUNOLOGY; PHENOTYPE; PREVENTION AND CONTROL;

ALLERGENS; DERMATITIS, ATOPIC; EMOLLIENTS; ENVIRONMENTAL EXPOSURE; EVIDENCE-BASED MEDICINE; GENE-ENVIRONMENT INTERACTION; HUMANS; PHENOTYPE; SKIN CREAM;

EID: 84969262786     PISSN: 10408703     EISSN: 1531698X     Source Type: Journal    
DOI: 10.1097/MOP.0000000000000374     Document Type: Review

References (60)

1. Leung DYM, Guttman-Yassky E. Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches. J Allergy Clin Immunol 2014; 134:769-779
2. Filanovsky MG, Pootongkam S, Tamburro JE, et al. The financial and emotional impact of atopic dermatitis on children and their families. J Pediatr 2016; 169:284-290
3. Blome C, Radtke MA, Eissing L, Augustin M. Quality of life in patients with atopic dermatitis: disease burden, measurement, and treatment benefit. Am J Clin Dermatol 2016; 17:163-169
4. Simpson EL, Bieber T, Eckert L, et al. Patient burden of moderate to severe atopic dermatitis (AD): insights from a phase 2b clinical trial of dupilumab in adults. J Am Acad Dermatol 2016; 74:491-498
5. Yu SH, Silverberg JI. Association between atopic dermatitis and depression in US adults. J Invest Dermatol 2015; 135:3183-3186
6. Paternoster L, Standl M, Waage J, et al. Multiancestry genome-wide association study of 21 000 cases and 95 000 controls identifies new risk loci for atopic dermatitis. Nat Genet 2015; 47:1449-1456
7. Kim EH, Kim S, Lee JH, et al. Indoor air pollution aggravates symptoms of atopic dermatitis in children. PLoS One 2015; 10:e0119501
8. Thyssen JP, Zirwas MJ, Elias PM. Potential role of reduced environmental UV exposure as a driver of the current epidemic of atopic dermatitis. J Allergy Clin Immunol 2015; 136:1163-1169
9. Werfel T, Heratizadeh A, Niebuhr M, et al. Exacerbation of atopic dermatitis on grass pollen exposure in an environmental challenge chamber. J Allergy Clin Immunol 2015; 136:96-103
10. Tsakok T, Marrs T, Mohsin M, et al. Does atopic dermatitis cause food allergy? A systematic review. J Allergy Clin Immunol 2016; 137:1071-1078
11. Schmitt J, Schwarz K, Baurecht H, et al. Atopic dermatitis is associated with an increased risk for rheumatoid arthritis and inflammatory bowel disease, and a decreased risk for type 1 diabetes. J Allergy Clin Immunol 2016; 137:130-136
12. Silverberg JI. Association between adult atopic dermatitis, cardiovascular disease, and increased heart attacks in three population-based studies. Allergy 2015; 70:1300-1308
13. Ewald DA, Malajian D, Krueger JG, et al. Meta-analysis derived atopic dermatitis (MADAD) transcriptome defines a robust AD signature highlighting the involvement of atherosclerosis and lipid metabolism pathways. BMC Medical Genomics 2015; 8:60
14. van Smeden J, Bouwstra JA. Stratum corneum lipids: their role for the skin barrier function in healthy subjects and atopic dermatitis patients. Curr Probl Dermatol 2016; 49:8-26
15. Yu HS, Kang MJ, Kwon JW, et al. Claudin-1 polymorphism modifies the effect of mold exposure on the development of atopic dermatitis and production of IgE. J Allergy Clin Immunol 2015; 135:827-830
16. Li K, Seok J, Park KY, et al. Copy-number variation of the filaggrin in Korean patients with atopic dermatitis: what really matters: 'number' or 'variation'? Br J Dermatol 2015; doi: 10.1111/bjd.14287. [Epub ahead of print]
17. Szegedi A. Filaggrin mutations in early-and late-onset atopic dermatitis. Br J Dermatol 2015; 172:320-321
18. De Marchi F, Piacentini GL, Piazza M, et al. Correlation of skin barrier impairment in atopic dermatitis with aeroallergen sensitization. Allergy Asthma Proc 2015; 36:e127-e133
19. Riethmuller C, McAleer MA, Koppes SA, et al. Filaggrin breakdown products determine corneocyte conformation in patients with atopic dermatitis. J Allergy Clin Immunol 2015; 136:1573-1580
20. Brough HA, Simpson A, Makinson K, et al. Peanut allergy: effect of environmental peanut exposure in children with filaggrin loss-of-function mutations. J Allergy Clin Immunol 2014; 134:867-875
21. Brough HA, Liu AH, Sicherer S, et al. Atopic dermatitis increases the effect of exposure to peanut antigen in dust on peanut sensitization and likely peanut allergy. J Allergy Clin Immunol 2015; 135:164-170
22. Thyssen JP, Tang L, Husemoen LL, et al. Filaggrin gene mutations are not associated with food and aeroallergen sensitization without concomitant atopic dermatitis in adults. J Allergy Clin Immunol 2015; 135:1375-1378
23. Cole C, Kroboth K, Schurch NJ, et al. Filaggrin-stratified transcriptomic analysis of pediatric skin identifies mechanistic pathways in patients with atopic dermatitis. J Allergy Clin Immunol 2014; 34:82-91
24. Esaki H, Ewald DA, Ungar B, et al. Identification of novel immune and barrier genes in atopic dermatitis by means of laser capture microdissection. J Allergy Clin Immunol 2015; 135:153-163
25. Ghosh D, Ding L, Sivaprasad U, et al. Multiple transcriptome data analysis reveals biologically relevant atopic dermatitis signature genes and pathways. PLoS One 2015; 10:e0144316
26. Hamilton JD, Ungar B, Guttman-Yassky E. Drug evaluation review: dupilumab in atopic dermatitis. Immunotherapy 2015; 7:1043-1058
27. Tsianakas A, Stander S. Dupilumab: a milestone in the treatment of atopic dermatitis. Lancet 2016; 387:4-5
28. Buzney CD, Gottlieb AB, Rosmarin D. Asthma and atopic dermatitis: a review of targeted inhibition of interleukin-4 and interleukin-13 as therapy for atopic disease. J Drugs Dermatol 2016; 15:165-171
29. Mashiko S, Bouguermouh S, Rubio M, et al. Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitis. J Allergy Clin Immunol 2015; 136:351-359
30. Shroff A, Guttman-Yassky E. Successful use of ustekinumab therapy in refractory severe atopic dermatitis. J Am Acad Dermatol Case Reports 2015; 1:25-26
31. Brauweiler AM, Goleva E, Leung DYM. IFN-g protects from staphylococcal alpha toxin induced keratinocyte death through apolipoprotein L1. J Invest Dermatol 2015; 136:658-664
32. Czarnowicki T, Malajian D, Shemer A, et al. Skin-homing and systemic T-cell subsets show higher activation in atopic dermatitis versus psoriasis. J Allergy Clin Immunol 2015; 136:208-211
33. Tatsuno K, Fujiyama T, Yamaguchi H, et al. TSLP directly interacts with skinhoming Th2 cells highly expressing its receptor to enhance IL-4 production in atopic dermatitis. J Invest Dermatol 2015; 135:3017-3024
34. Leung DYM. Atopic dermatitis: age and race do matter! J Allergy Clin Immunol 2015; 136:1265-1267
35. Noda S, Suarez-Farinas M, Ungar B, et al. The Asian atopic dermatitis phenotype combines features of atopic dermatitis and psoriasis with increased TH17 polarization. J Allergy Clin Immunol 2015; 136:1254-1264
36. Czarnowicki T, Esaki H, Gonzalez J, et al. Early pediatric atopic dermatitis shows only a cutaneous lymphocyte antigen (CLA)(þ) TH2/TH1 cell imbalance, whereas adults acquire CLA(þ) TH22/TC22 cell subsets. J Allergy Clin Immunol 2015; 136:941-951
37. Czarnowicki T, Gonzalez J, Shemer A, et al. Severe atopic dermatitis is characterized by selective expansion of circulating TH2/TC2 and TH22/ TC22, but not TH17/TC17, cells within the skin-homing T-cell population. J Allergy Clin Immunol 2015; 136:104-115
38. Williams MR, Gallo RL. The role of the skin microbiome in atopic dermatitis. Curr Allergy Asthma Rep 2015; 15:65
39. Tauber M, Balica S, Hsu CY, et al. Staphylococcus aureus density on lesional and nonlesional skin is strongly associated with disease severity in atopic dermatitis. J Allergy Clin Immunol 2015; 137:1272-1274
40. Kobayashi T, Glatz M, Horiuchi K, et al. Dysbiosis and Staphylococcus aureus colonization drives inflammation in atopic dermatitis. Immunity 2015; 42:756-766
41. Chaptini C, Quinn S, Marshman G. Methicillin-resistant Staphylococcus aureus in children with atopic dermatitis from 1999 to 2014: a longitudinal study. Australas J Dermatol 2015; doi: 10.1111/ajd.12371. [Epub ahead of print]
42. Oyoshi MK, Venturelli N, Geha RS. Thymic stromal lymphopoietin and IL-33 promote skin inflammation and vaccinia virus replication in a mouse model of atopic dermatitis. J Allergy Clin Immunol 2016; doi: 10.1016/j.jaci. 2015.12.1304. [Epub ahead of print]
43. Gao L, Bin L, Rafaels NM, et al. Targeted deep sequencing identifies rare lossof-function variants in IFNGR1 for risk of atopic dermatitis complicated by eczema herpeticum. J Allergy Clin Immunol 2015; 136:1591-1600
44. Brar K, Leung DY. Recent considerations in the use of recombinant interferon gamma for biological therapy of atopic dermatitis. Expert Opin Biol Ther 2016; 16:507-514
45. O'Donovan SM, J OBH, Murray DM, et al. Neonatal adiposity increases the risk of atopic dermatitis during the first year of life. J Allergy Clin Immunol 2016; 137:108-117
46. Lynde CW, Andriessen A, Bertucci V, et al. The skin microbiome in atopic dermatitis and its relationship to emollients. J Cutan Med Surg 2016; 20:21-28
47. Simpson EL, Chalmers JR, Williams HC. Emollient enhancement of skin barrier from birth offers effective atopic dermatitis prevention. J Allergy Clin Immunol 2014; 134:818-823
48. Horimukai K, Morita K, Narita M, et al. Application of moisturizer to neonates prevents development of atopic dermatitis. J Allergy Clin Immunol 2014; 134:824-830
49. Kelleher M, Dunn-Galvin A, Hourihane JO, et al. Skin barrier dysfunction measured by transepidermal water loss at 2 days and 2 months predates and predicts atopic dermatitis at 1 year. J Allergy Clin Immunol 2015; 135:930-935
50. Horimukai K, Morita K, Narita M, et al. Transepidermal water loss measurement during infancy can predict the subsequent development of atopic dermatitis regardless of filaggrin mutations. Allergol Int 2016; 65:103-108
51. Kim J, Kim BE, Lee J, et al. Epidermal thymic stromal lymphopoietin predicts the development of atopic dermatitis during infancy. J Allergy Clin Immunol 2016; 137:1282-1285
52. Jones AL, Curran-Everett D, Leung DYM. Food allergy is associated with Staphylococcus aureus colonization in children with atopic dermatitis. J Allergy Clin Immunol 2016; 137:1247-1248
53. Shi VY, Foolad N, Ornelas JN, et al. Comparing the effect of bleach and water baths on skin barrier function in atopic dermatitis: a split-body randomized controlled trial. Br J Dermatol 2016; doi: 10.1111/bjd.14483. [Epub ahead of print]
54. Weidinger S, Baurecht H, Schmitt J. A critical appraisal of the PETITE study report: topical corticosteroids are safe and effective in the long-term treatment of infantile atopic dermatitis. Pediatrics 2015; 136:e1485
55. Eichenfield DZ, Eichenfield LF. Pimecrolimus is safe and effective in treating atopic dermatitis. J Pediatr 2015; 167:1169-1172
56. Cury Martins J, Martins C, Aoki V, et al. Topical tacrolimus for atopic dermatitis. Cochrane Database Syst Rev 2015; 7:CD009864
57. Fishbein AB, Vitaterna O, Haugh IM, et al. Nocturnal eczema: review of sleep and circadian rhythms in children with atopic dermatitis and future research directions. J Allergy Clin Immunol 2015; 136:1170-1177
58. Radhakrishna N, Prickett S, Phan T, et al. Anaphylaxis to oats after cutaneous sensitization by oatmeal in skin products used for the treatment of atopic dermatitis. J Allergy Clin Immunol Pract 2016; 4:152-153
59. Chang YS, Lin MH, Lee JH, et al. Melatonin supplementation for children with atopic dermatitis and sleep disturbance: a randomized clinical trial. JAMA Pediatr 2016; 170:35-42
60. Suarez-Farinas M, Ungar B, Correa da Rosa J, et al. RNA sequencing atopic dermatitis transcriptome profiling provides insights into novel disease mechanisms with potential therapeutic implications. J Allergy Clin Immunol 2015; 135:1218-1227